Source: Annual Congress 2003 - Epidemiological aspects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. M. Gagnon, D. W. Maple, A. R. Levy, J. S. Hurley, F. J. Frost, M. D. Spencer, A. H. Briggs (Vancouver, Canada; Albuquerque, United States Of America; London, Oxford, United Kingdom). Economic outcomes in the United States of treating COPD with inhaled corticosteroids and long-acting β-agonists in a managed care setting. Eur Respir J 2003; 22: Suppl. 45, 1462

Member's Comments

No comment yet.

Related content which might interest you: Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007 De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Asthma control among patients receiving inhaled corticosteroids in general practice in Thailand Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 Economic implications of treatment pathways of asthma exacerbations managed in primary care in Spain Source: Eur Respir J 2001; 18: Suppl. 33, 235s Year: 2001 Cost of asthma exacerbations managed in primary care in Spain Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001 Oral corticosteroid prescription patterns in asthma care in Italy Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Treatment of asthma exacerbations managed in primary care in Spain Source: Eur Respir J 2001; 18: Suppl. 33, 235s Year: 2001 Prescription of inhaled corticosteroids for COPD in general practice in Denmark – changes after participating in an educational programme Source: Annual Congress 2008 - Management of COPD Year: 2008 Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice Source: Annual Congress 2010 - Management of airway disease Year: 2010 COPD guides and inhaled corticosteroids. Is there an adequate use in primary care? Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Inhaled corticosteroids in stable COPD – international recommendations and reality in Bulgaria Source: International Congress 2017 – COPD management Year: 2017 SABA and ICS use among mild asthma patients in UK primary care Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Inhaled steroids prescribing in patients with COPD in the community Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001 Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015